A detailed history of Harbour Investments, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Harbour Investments, Inc. holds 11,132 shares of NVO stock, worth $1.2 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
11,132
Previous 11,719 5.01%
Holding current value
$1.2 Million
Previous $1.67 Million 20.75%
% of portfolio
0.04%
Previous 0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$119.07 - $145.42 $69,894 - $85,361
-587 Reduced 5.01%
11,132 $1.33 Million
Q2 2024

Jul 26, 2024

BUY
$122.71 - $146.91 $391,199 - $468,349
3,188 Added 37.37%
11,719 $1.67 Million
Q1 2024

Jul 22, 2024

BUY
$102.11 - $135.92 $79,237 - $105,473
776 Added 10.01%
8,531 $1.1 Million
Q4 2023

Feb 16, 2024

BUY
$87.78 - $105.45 $105,248 - $126,434
1,199 Added 18.29%
7,755 $802,000
Q3 2023

Nov 15, 2023

BUY
$90.94 - $199.54 $298,010 - $653,892
3,277 Added 99.94%
6,556 $596,000
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $2,963 - $3,280
19 Added 0.58%
3,279 $530,000
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $6,617 - $7,956
50 Added 1.56%
3,260 $518,000
Q4 2022

Feb 15, 2023

BUY
$102.55 - $135.33 $186,230 - $245,759
1,816 Added 130.27%
3,210 $434,000
Q2 2022

Aug 15, 2022

SELL
$103.24 - $121.81 $224,959 - $265,423
-2,179 Reduced 60.99%
1,394 $155,000
Q4 2021

Feb 16, 2022

SELL
$95.88 - $117.08 $377,767 - $461,295
-3,940 Reduced 52.44%
3,573 $400,000
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $57,743 - $72,928
684 Added 10.02%
7,513 $721,000
Q2 2021

Aug 16, 2021

BUY
$67.66 - $84.76 $293,915 - $368,197
4,344 Added 174.81%
6,829 $572,000
Q1 2021

Aug 17, 2021

BUY
$67.06 - $75.82 $149,879 - $169,457
2,235 Added 894.0%
2,485 $168,000
Q1 2021

May 12, 2021

BUY
$67.06 - $75.82 $16,765 - $18,955
250 New
250 $17,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $243B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.